Delivery Order SPE2DB24D2003-SPE2DB25FXLU0
- Not listed
- The Defense Logistics Agency awarded a $46,054.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Taltz 80 mg/mL auto-injector (2-pack) pharmaceutical product. The contract, which is set to be completed by August 1, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This competitively awarded delivery order represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $3,320.62 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for Taltz 80 mg/ml autoinjector medication. This is a firm fixed price, competitively awarded contract with performance completion targeted for August 1, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Taltz 80 mg/ml auto-injector two-packs, with a firm fixed price ceiling value of $46,869.29. This non-set-aside competitive award is classified as a delivery order with an ultimate completion date of August 12, 2025, and represents a continuation of the vendor's extensive pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of TALTZ 80 mg/ml auto-injector two-packs with a ceiling value of $8,391.13. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $3,320.62 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on August 7, 2025, with ultimate completion by August 8, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TALTZ is a biologic medication used to treat autoimmune conditions, and this procurement represents a routine...
- The Defense Logistics Agency awarded a $19,447.53 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of TALTZ 80 MG/ML auto-injector (2-pack) pharmaceutical products. This firm fixed-price delivery order, which concludes on August 15, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,228.37 on August 11, 2025, for the supply of TALTZ 80 MG/ML AutoInjector (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions and represents a routine pharmaceutical procurement through established federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Taltz 80 mg/ml autoinjector on August 15, 2025, with a ceiling value of $3,524.56. This is a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. The order is scheduled for completion by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Taltz is a biologic medication used to...
- The Defense Logistics Agency awarded a $24,730.89 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Taltz 80 mg/ml autoinjector. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 18, 2025, and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply arrangement with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLU0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,965.18 to AmerisourceBergen Drug Corp for Taltz 80 mg/ml auto-injector two-packs on August 18, 2025, with completion expected by August 19, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Taltz is a biologic medication used to treat inflammatory conditions, and this delivery represents a routine pharmaceutical procurement supporting federal military and healthcare system needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This prime pharmaceutical vendor contract enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's status as a critical federal pharmaceutical distributor reflects its capability to meet the Defense Department's medical supply chain requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 8/18/25 |